DeCaprio David 4

What Happened
David DeCaprio, President & COO and a director of Firefly Neuroscience, reported the vesting of 44,872 restricted stock units (RSUs) on March 10, 2026. The Form 4 lists the transaction as an award/acquisition (code A) at $0.00 per share (reported value $0). These vested RSUs are part of a larger April 18, 2025 grant under the company’s 2024 Long‑Term Incentive Plan.

Key Details

• Transaction date: 2026-03-10; reported on Form 4 filed 2026-03-12.
• Transaction type/price: Award (A) of 44,872 shares at $0.00 per share (reported $0).
• Shares owned after transaction: Not disclosed in the filing.
• Footnote: On 4/18/2025 DeCaprio was granted 263,952 RSUs; on 3/10/2026 the Compensation Committee determined performance conditions were met for vesting of 44,872 of those shares.
• Timeliness: Filing appears timely (reported within two business days of the transaction).

Context
These were performance‑based RSUs vesting under the company’s long‑term incentive plan—not an open‑market purchase or sale. Awards like this are a form of executive compensation and do not, by themselves, indicate the insider bought or sold shares in the market.